WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their INVA stock forecasts and price targets.

Forecast return on equity

Is INVA forecast to generate an efficient return?
Company
5.31%
Industry
1.39%
Market
6.76%
INVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INVA forecast to generate an efficient return on assets?
Company
2.8%
Industry
-1.76%
INVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INVA earnings growth forecast

How is INVA forecast to perform vs Biotechnology companies and vs the US market?
Company
0%
Industry
22.22%
Market
75.12%
INVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
INVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
INVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

INVA revenue growth forecast

How is INVA forecast to perform vs Biotechnology companies and vs the US market?
Company
-32.71%
Industry
1,251.4%
Market
29.08%
INVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INVA$13.65N/AN/A
SAVA$20.75$124.00+497.59%Buy
APGE$17.27$34.33+98.80%Strong Buy
ALPN$15.07$22.50+49.30%Strong Buy
EDIT$10.74$14.00+30.35%Strong Buy

Innoviva Stock Forecast FAQ

What is INVA's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: INVA) forecast ROE is 5.31%, which is considered weak.

If you're new to stock investing, here's how to buy Innoviva stock.

What is INVA's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: INVA) forecast ROA is 2.8%, which is higher than the forecast US Biotechnology industry average of -1.76%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.